LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
USA - NASDAQ:LMAT - US5255582018 - Common Stock
86.48 USD
-0.51 (-0.59%)
We assign a fundamental rating of 7 out of 10 to LMAT. LMAT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. LMAT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LMAT has a correct valuation and a medium growth rate. These ratings would make LMAT suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
In the past year LMAT had a positive cash flow from operations.
Each year in the past 5 years LMAT has been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
LMAT has a better Return On Assets (8.16%) than 90.43% of its industry peers.
LMAT has a better Return On Equity (12.99%) than 88.30% of its industry peers.
With an excellent Return On Invested Capital value of 7.70%, LMAT belongs to the best of the industry, outperforming 83.51% of the companies in the same industry.
LMAT had an Average Return On Invested Capital over the past 3 years of 8.26%. This is in line with the industry average of 8.98%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROIC | 7.7% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
LMAT has a better Profit Margin (20.08%) than 93.09% of its industry peers.
LMAT's Profit Margin has improved in the last couple of years.
LMAT's Operating Margin of 23.34% is amongst the best of the industry. LMAT outperforms 94.68% of its industry peers.
LMAT's Operating Margin has improved in the last couple of years.
LMAT's Gross Margin of 69.11% is fine compared to the rest of the industry. LMAT outperforms 76.60% of its industry peers.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
LMAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, LMAT has more shares outstanding
The number of shares outstanding for LMAT has been increased compared to 5 years ago.
The debt/assets ratio for LMAT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 7.44 indicates that LMAT is not in any danger for bankruptcy at the moment.
The Altman-Z score of LMAT (7.44) is better than 86.17% of its industry peers.
The Debt to FCF ratio of LMAT is 3.21, which is a good value as it means it would take LMAT, 3.21 years of fcf income to pay off all of its debts.
LMAT's Debt to FCF ratio of 3.21 is amongst the best of the industry. LMAT outperforms 83.51% of its industry peers.
LMAT has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.46, LMAT is in line with its industry, outperforming 45.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Altman-Z | 7.44 |
ROIC/WACC0.9
WACC8.58%
2.3 Liquidity
A Current Ratio of 13.96 indicates that LMAT has no problem at all paying its short term obligations.
The Current ratio of LMAT (13.96) is better than 98.40% of its industry peers.
A Quick Ratio of 11.74 indicates that LMAT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 11.74, LMAT belongs to the best of the industry, outperforming 96.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.78% over the past year.
LMAT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.13% yearly.
The Revenue has grown by 13.07% in the past year. This is quite good.
Measured over the past years, LMAT shows a quite strong growth in Revenue. The Revenue has been growing by 13.41% on average per year.
EPS 1Y (TTM)26.78%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%53.06%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.76% yearly.
LMAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.67% yearly.
EPS Next Y19.93%
EPS Next 2Y14.3%
EPS Next 3Y12.64%
EPS Next 5Y9.76%
Revenue Next Year13.86%
Revenue Next 2Y11.2%
Revenue Next 3Y10.46%
Revenue Next 5Y9.67%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
LMAT is valuated quite expensively with a Price/Earnings ratio of 37.28.
Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than the industry average as 70.21% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 25.56, LMAT is valued a bit more expensive.
LMAT is valuated quite expensively with a Price/Forward Earnings ratio of 34.12.
Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 71.28% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.62. LMAT is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.28 | ||
| Fwd PE | 34.12 |
4.2 Price Multiples
LMAT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 73.40% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LMAT is valued a bit cheaper than the industry average as 75.53% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.42 | ||
| EV/EBITDA | 23.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LMAT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of LMAT may justify a higher PE ratio.
LMAT's earnings are expected to grow with 12.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.87
PEG (5Y)2.18
EPS Next 2Y14.3%
EPS Next 3Y12.64%
5. Dividend
5.1 Amount
With a yearly dividend of 0.89%, LMAT is not a good candidate for dividend investing.
LMAT's Dividend Yield is rather good when compared to the industry average which is at 1.69. LMAT pays more dividend than 92.55% of the companies in the same industry.
With a Dividend Yield of 0.89, LMAT pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.89% |
5.2 History
On average, the dividend of LMAT grows each year by 13.60%, which is quite nice.
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
34.45% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.45%
EPS Next 2Y14.3%
EPS Next 3Y12.64%
NASDAQ:LMAT (11/18/2025, 12:39:34 PM)
86.48
-0.51 (-0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.25%
Inst Owner Change-3.94%
Ins Owners7.8%
Ins Owner Change-9.34%
Market Cap1.96B
Revenue(TTM)240.87M
Net Income(TTM)47.12M
Analysts78.75
Price Target106.72 (23.4%)
Short Float %5.83%
Short Ratio7.77
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.89% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP34.45%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-5.52%
Max EPS beat(2)3.81%
EPS beat(4)2
Avg EPS beat(4)1.56%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.62%
EPS beat(12)8
Avg EPS beat(12)3.08%
EPS beat(16)8
Avg EPS beat(16)-1.76%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.79%
Max Revenue beat(2)1.83%
Revenue beat(4)3
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.31%
Revenue beat(12)6
Avg Revenue beat(12)-0.07%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)-0.15%
PT rev (3m)0.12%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)5.92%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.28 | ||
| Fwd PE | 34.12 | ||
| P/S | 8.34 | ||
| P/FCF | 37.42 | ||
| P/OCF | 33.32 | ||
| P/B | 5.4 | ||
| P/tB | 7.43 | ||
| EV/EBITDA | 23.52 |
EPS(TTM)2.32
EY2.68%
EPS(NY)2.53
Fwd EY2.93%
FCF(TTM)2.31
FCFY2.67%
OCF(TTM)2.6
OCFY3%
SpS10.36
BVpS16.02
TBVpS11.64
PEG (NY)1.87
PEG (5Y)2.18
Graham Number28.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROCE | 10.02% | ||
| ROIC | 7.7% | ||
| ROICexc | 18.52% | ||
| ROICexgc | 32.83% | ||
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% | ||
| FCFM | 22.3% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Debt/EBITDA | 2.59 | ||
| Cap/Depr | 63.73% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.57% | ||
| Profit Quality | 111.05% | ||
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 | ||
| Altman-Z | 7.44 |
F-Score5
WACC8.58%
ROIC/WACC0.9
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)26.78%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%53.06%
EPS Next Y19.93%
EPS Next 2Y14.3%
EPS Next 3Y12.64%
EPS Next 5Y9.76%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
Revenue Next Year13.86%
Revenue Next 2Y11.2%
Revenue Next 3Y10.46%
Revenue Next 5Y9.67%
EBIT growth 1Y20%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year43.57%
EBIT Next 3Y22.42%
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y129.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%
LEMAITRE VASCULAR INC / LMAT FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
Can you provide the valuation status for LEMAITRE VASCULAR INC?
ChartMill assigns a valuation rating of 4 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
How profitable is LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 8 / 10.
What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 37.28 and the Price/Book (PB) ratio is 5.4.
What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?
The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 19.93% in the next year.